In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination

Significant recent advances in cancer immunotherapeutics include the vaccination of cancer patients with tumor antigen-associated peptide-pulsed dendritic cells (DCs). DC vaccines with homogeneous, mature, and functional activities are required to achieve effective acquired immunity; however, the yi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimodaira, Shigetaka, Yanagisawa, Ryu, Koya, Terutsugu, Hirabayashi, Koichi, Higuchi, Yumiko, Sakamoto, Takuya, Togi, Misa, Kato, Tomohisa, Kobayashi, Takashi, Koizumi, Tomonobu, Koido, Shigeo, Sugiyama, Haruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789603/
https://www.ncbi.nlm.nih.gov/pubmed/31546936
http://dx.doi.org/10.3390/vaccines7030120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789603/
https://www.ncbi.nlm.nih.gov/pubmed/31546936
http://dx.doi.org/10.3390/vaccines7030120

Ejemplares similares